Dravet Syndrome Market 2020 - 2026, Details in Relation to the Value, Supply Chain Analysis

(The Express Wire via Comtex)

Proactive role played by regulatory bodies in approving novel drugs will fuel the global Dravet syndrome market size growth during the forecast period. Dravet syndrome is a severe form of epilepsy that occurs in the first year of life and becomes a lifelong condition characterized by frequent and prolonged seizure episodes. It is a rare disorder, affecting 1 in every 15,700 Americans, according to the National Institutes of Health. Since it’s a rare disease, it requires unique treatment methods and many companies and institutions are coming to the fore with novel therapies. They are receiving encouragement from regulatory bodies such as the Food and Drug Administration (FDA) of the US. For example, the FDA, for the first time, cleared a cannabis-derived purified drug called epidiolex in June 2018. Such supportive regulatory policies are expected to emerge as one of the key Dravet syndrome market trends in the forthcoming years.

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dravet-syndrome-market-101181

Leading Players operating in the Dravet Syndrome Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Zogenix
  • Epygenix Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • PTC Therapeutics
  • GW Pharmaceuticals plc.
  • Ovid Therapeutics

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Dravet Syndrome Market.

Please visit:https://www.fortunebusinessinsights.com/industry-reports/dravet-syndrome-market-101181

Possibility of Unusual Side Effects May Impede Market Growth

The Dravet syndrome market analysis shows that it will not be smooth-sailing for this market as drugs treating Dravet are known to have certain side effects. According to the Epilepsy Foundation, some of the common side effects of these medicines include stomach discomfort, blurred vision, and fatigue. However, the worrying factor is the irregular side effects that the Epilepsy Foundation has identified. For example, these drugs can induce a steep drop in the body’s White Blood Cells (WBCs) that are critical for fighting infections. They can also lead to problems in the pancreas and the liver and can also cause the platelet count to plummet. As a result, these side effects can slow down the uptake of Dravet medication and hinder the growth of this market.

The report covers:

  • Global Dravet Syndrome Market trends, with detailed analysis on consumer trends and manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dravet-syndrome-market-101181

North America and Europe to Hold Lion’s Share in the Market

Regionally, North America is projected to dominate the Dravet syndrome market share on account of presence of important market players in the region, rising investment in RandD, and launch of new products. Timely regulatory clearances are incentivizing players in North America to develop novel products, which is also pushing the market forward in the region. Growing awareness of the Dravet syndrome will drive the market in Asia-Pacific, while the market in Latin America is yet to be tapped by companies.

Dravet Syndrome Market Segmentation:

By Treatment

  • Drugs
  • Vagus Nerve Stimulation (VNS)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Dravet Syndrome Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Dravet Syndrome Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]


Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Dravet Syndrome Market 2020 - 2026, Details in Relation to the Value, Supply Chain Analysis

comtex tracking